| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |